Overview

Open Label Assessment of Long-Term Safety and Utility

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to monitor the long-term analgesic effectiveness, safety, and utility of oxymorphone ER for the relief of moderate to severe pain due to cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Endo Pharmaceuticals
Treatments:
Oxymorphone